Evidence map›Paper›PMID 42208546›Full record

ArticleFEBS open bio2026

Guiding AlphaFold to predict how Munc13-1 opens Syntaxin-1.

Madhurima Chattopadhyay, Junjie Xu, Josep Rizo

Abstract read
In one paragraph

Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Madhurima ChattopadhyayDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID https://orcid.org/0000-0001-8900-163X
Junjie XuDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Josep RizoDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID https://orcid.org/0000-0003-1773-8311

Funding

Mechanisms of neurotransmitter release and its regulationR35NS097333 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI RIZOREY, JOSE · 2017 to 2024
$7.0M
NINDS NIH HHS R35 NS097333Welch Foundation I1304
6 · The paper itself

Abstract

The SNARE proteins syntaxin-1, synaptobrevin, and SNAP-25 mediate neurotransmitter release by forming SNARE complexes that fuse synaptic vesicles with the plasma membrane. SNARE complex assembly is orchestrated by Munc18-1 and Munc13-1 through a highly regulated pathway that starts with syntaxin-1 folded into a closed conformation and bound to Munc18-1. It is well-established that Munc13-1 opens syntaxin-1, likely acting catalytically, and that this step is crucial for neurotransmitter release. However, the underlying molecular mechanism remains unknown because it is difficult to obtain structural information on Munc13-1-syntaxin-1 interactions experimentally. Initial attempts with AlphaFold using the syntaxin-1 cytoplasmic region yielded structures of Munc13-1-syntaxin-1 complexes but syntaxin-1 remained closed. Interestingly, when using a shorter syntaxin-1 fragment designed to destabilize the closed conformation, AlphaFold generated a model of Munc13-1 bound to an open syntaxin-1 conformation that explains abundant experimental data and suggests an attractive hypothesis of how Munc13-1 opens syntaxin-1. These results indicate that a judicious selection of protein fragments can help AlphaFold to predict structures of kinetic intermediates in complex biomolecular processes.

Indexed as

AlphaFoldconformational changeMunc13neurotransmitter releaseSNAREsSyntaxin

Identifiers

PMID42208546
PMCPMC13398699

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.